A "REAL-WORLD" CHARACTERIZATION OF MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Strand, V. [1 ]
Johnson, J. [2 ]
Vandeloo, C. [3 ]
Galateanu, C. [3 ]
Lobosco, S. [2 ]
机构：
[1] Biopharmaceut Consultant, Portola Valley, CA USA
[2] Adelphi Real World Ltd, Macclesfield, Cheshire, England
[3] UCB Pharma, Brussels, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1828
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0101
引用
下载
收藏
页码：626 / 627
页数：2
相关论文
共 50 条
  • [21] Moderate to Severe Depression in Patients with Systemic Lupus Erythematosus
    Chalhoub, Nathalie
    Luggen, Michael
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [22] A real-world study on the association of clinical characteristics of systemic lupus erythematosus with flare
    Wang, Xiangyu
    Upreti, Bibhuti
    Yang, Yifan
    Cui, Ruomei
    Liu, Shuang
    Bai, Ru
    Cheng, Yuqi
    Xu, Jian
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [23] Deep Neck Infection in Systemic Lupus Erythematosus Patients: Real-World Evidence
    Geng-He Chang
    Yi-Cheng Su
    Ko-Ming Lin
    Chia-Yen Liu
    Yao-Hsu Yang
    Pey-Jium Chang
    Meng-Hung Lin
    Chuan-Pin Lee
    Cheng-Ming Hsu
    Yao-Te Tsai
    Ching-Yuan Wu
    Ming-Shao Tsai
    Scientific Reports, 10
  • [24] REAL-WORLD EVALUATION OF HEALTH DISPARITIES IN TREATMENT PATTERNS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Nayak, P.
    Cyhaniuk, A.
    Prasad, S.
    Pfeffer, D.
    Shokoohi, M.
    Kish, J.
    VALUE IN HEALTH, 2023, 26 (06) : S207 - S207
  • [25] Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
    Shirley P. Huang
    Sonya J. Snedecor
    Sakina Nanji
    Emily Lloyd
    Christopher F. Bell
    Rheumatology and Therapy, 2022, 9 : 975 - 991
  • [26] Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
    Huang, Shirley P.
    Snedecor, Sonya J.
    Nanji, Sakina
    Lloyd, Emily
    Bell, Christopher F.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 975 - 991
  • [27] Deep Neck Infection in Systemic Lupus Erythematosus Patients: Real-World Evidence
    Chang, Geng-He
    Su, Yi-Cheng
    Lin, Ko-Ming
    Liu, Chia-Yen
    Yang, Yao-Hsu
    Chang, Pey-Jium
    Lin, Meng-Hung
    Lee, Chuan-Pin
    Hsu, Cheng-Ming
    Tsai, Yao-Te
    Wu, Ching-Yuan
    Tsai, Ming-Shao
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting
    Anjo, C.
    Mascaro, J-M, Jr.
    Espinosa, G.
    Cervera, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2019, 48 (06) : 469 - 473
  • [29] Efficacy and safety of belimumab/low-dose cyclophosphamide therapy in moderate-to-severe systemic lupus erythematosus
    Cheng, Hao
    Zhang, Xiao-ying
    Yang, Hui-dan
    Yu, Zhen
    Yan, Cheng-lan
    Gao, Chong
    Wen, Hong-yan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus.
    Furie, Richard A.
    Scheinberg, Morton A.
    Leon, Gustavo
    Ramiterre, Edgar B.
    Thomas, Matthew
    Martin, Renee S.
    Petri, Michelle A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4169 - 4169
12345